Trial intelligence / Profile preview

Lipid Response to Acute Olanzapine in Healthy Adults

NCT04181385Phase 3Unknown

Sponsor
University Health Network
Start
Jan 2019
Primary completion
Jan 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of olanzapine in schizophrenia, sponsored by University Health Network. Status: unknown.

02

Drugs

olanzapine
03

Conditions

schizophrenia

Beyond the preview

Go deeper on NCT04181385.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04181385.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call